Firstword - Executive Plus Edition?pslrid=58CBC084B3B049F4888A7D4F1ECA771A - Where people who know first, go first
    lorazepam

10 documents citing lorazepam

06/29/2010   New data for Vimpat (lacosamide) showed sustained efficacy for up to 5 years and improved seizure control when added to a broad range of antiepileptic drugs - (UCB)
 
08/25/2009   Survey of US physicians finds off-label prescribing often not based on evidence - (Ref. The New York Times; Times of the Internet; Pharmacoepidemiology and Drug Safety)
 
09/25/2008   Amarin announces financial results for second quarter 2008 - (Amarin)
 
04/01/2008   Merck's investigational rolofylline associated with improved dyspnea and preserved renal function in acute heart failure patients in a Phase III pilot study - (Merck)
 
03/03/2008   Tamoxifen may help control bipolar mania, study suggests - (Ref. Bloomberg; Archives of General Psychiatry)
 
01/25/2008   Mylan provides update relating to ongoing lorazepam and clorazepate litigation - (Mylan)
 
01/09/2008   Amarin announces successful outcome of nasal lorazepam study - (CNN Money)
 
05/24/2007   Drug study on kids won't require consent - (USA Today)
 
03/06/2007   Amarin Corp acquires global license for epilepsy drug based on Elan patent - (Hemscott)
 
05/25/2005   New investigational data using intramuscular administration of aripiprazole in patients with acute bipolar mania and schizophrenia - (MarketWatch)
 
 
 
FirstWord PLUS To add lorazepam
to your ProductWatch click here
Terms of Use | Privacy Policy | All Contents Copyright © 2010 Doctor's Guide Publishing Limited. All Rights Reserved.